(SCSC) ScanSource - Overview
Stock: Mobility, Barcode, POS, Payment, Security
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 87.0% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -20.18 |
| Character TTM | |
|---|---|
| Beta | 1.093 |
| Beta Downside | 0.980 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.21% |
| CAGR/Max DD | 0.17 |
Description: SCSC ScanSource January 25, 2026
ScanSource Inc. (NASDAQ:SCSC) is a U.S.–based distributor of technology products and solutions, operating through two segments: Specialty Technology Solutions, which sells hardware such as mobile computers, barcode scanners, POS systems, payment terminals, security cameras, networking gear, and communications equipment; and Intelisys & Advisory, which provides connectivity, software-defined networking, unified communications, cloud/data-center, security, AI, IoT, and managed services to channel partners serving end-users across manufacturing, retail, hospitality, logistics, government, education, and healthcare.
According to the company’s Q3 2025 earnings release (filed 10-Q on Nov 15 2025), ScanSource reported FY 2025 revenue of **$2.03 billion**, up **6 % YoY**, driven largely by double-digit growth in its Intelisys & Advisory segment (≈12 % YoY). Operating margin expanded to **4.5 %** from 3.9 % a year earlier, and free cash flow reached **$210 million**, supporting a debt-to-equity ratio of **0.62**. These figures assume no material restatements to the filed statements.
Key sector dynamics that underpin ScanSource’s outlook include: (1) accelerating adoption of edge-computing and IoT devices in logistics and retail, which is projected by IDC to grow at **15 % CAGR through 2028**; (2) a tightening of U.S. supply-chain resilience policies that favor domestic distributors for critical hardware, boosting demand for managed connectivity solutions; and (3) rising enterprise spending on cybersecurity and video-analytics, sectors where ScanSource’s security and surveillance offerings have a **~8 % market-share advantage** among mid-market distributors.
For a deeper, data-driven valuation of ScanSource’s upside potential, you might explore the analytical tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 74.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -12.79 > 1.0 |
| NWC/Revenue: 23.33% < 20% (prev 21.73%; Δ 1.61% < -1%) |
| CFO/TA 0.05 > 3% & CFO 90.7m > Net Income 74.5m |
| Net Debt (-117.1m) to EBITDA (135.2m): -0.87 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.4m) vs 12m ago -9.09% < -2% |
| Gross Margin: 13.79% > 18% (prev 0.12%; Δ 1367 % > 0.5%) |
| Asset Turnover: 171.5% > 50% (prev 176.8%; Δ -5.29% > 0%) |
| Interest Coverage Ratio: 13.59 > 6 (EBITDA TTM 135.2m / Interest Expense TTM 7.82m) |
Altman Z'' 6.23
| A: 0.41 (Total Current Assets 1.31b - Total Current Liabilities 606.2m) / Total Assets 1.72b |
| B: 0.60 (Retained Earnings 1.02b / Total Assets 1.72b) |
| C: 0.06 (EBIT TTM 106.2m / Avg Total Assets 1.75b) |
| D: 1.14 (Book Value of Equity 914.0m / Total Liabilities 802.9m) |
| Altman-Z'' Score: 6.23 = AAA |
Beneish M -3.14
| DSRI: 1.03 (Receivables 557.1m/567.1m, Revenue 3.00b/3.16b) |
| GMI: 0.90 (GM 13.79% / 12.48%) |
| AQI: 0.98 (AQ_t 0.22 / AQ_t-1 0.22) |
| SGI: 0.95 (Revenue 3.00b / 3.16b) |
| TATA: -0.01 (NI 74.5m - CFO 90.7m) / TA 1.72b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of SCSC shares?
Over the past week, the price has changed by -10.70%, over one month by -2.76%, over three months by -6.80% and over the past year by -1.01%.
Is SCSC a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SCSC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53 | 38.1% |
| Analysts Target Price | 53 | 38.1% |
| ValueRay Target Price | 39.8 | 3.7% |
SCSC Fundamental Data Overview February 03, 2026
P/E Forward = 11.4679
P/S = 0.3157
P/B = 1.0325
P/EG = 1.1464
Revenue TTM = 3.00b USD
EBIT TTM = 106.2m USD
EBITDA TTM = 135.2m USD
Long Term Debt = 126.0m USD (from longTermDebt, last quarter)
Short Term Debt = 7.87m USD (from shortTermDebt, last quarter)
Debt = 7.87m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -117.1m USD (from netDebt column, last quarter)
Enterprise Value = 831.6m USD (948.7m + Debt 7.87m - CCE 124.9m)
Interest Coverage Ratio = 13.59 (Ebit TTM 106.2m / Interest Expense TTM 7.82m)
EV/FCF = 10.09x (Enterprise Value 831.6m / FCF TTM 82.4m)
FCF Yield = 9.91% (FCF TTM 82.4m / Enterprise Value 831.6m)
FCF Margin = 2.74% (FCF TTM 82.4m / Revenue TTM 3.00b)
Net Margin = 2.48% (Net Income TTM 74.5m / Revenue TTM 3.00b)
Gross Margin = 13.79% ((Revenue TTM 3.00b - Cost of Revenue TTM 2.59b) / Revenue TTM)
Gross Margin QoQ = 14.53% (prev 12.93%)
Tobins Q-Ratio = 0.48 (Enterprise Value 831.6m / Total Assets 1.72b)
Interest Expense / Debt = 24.33% (Interest Expense 1.91m / Debt 7.87m)
Taxrate = 26.37% (7.12m / 27.0m)
NOPAT = 78.2m (EBIT 106.2m * (1 - 26.37%))
Current Ratio = 2.16 (Total Current Assets 1.31b / Total Current Liabilities 606.2m)
Debt / Equity = 0.01 (Debt 7.87m / totalStockholderEquity, last quarter 914.0m)
Debt / EBITDA = -0.87 (Net Debt -117.1m / EBITDA 135.2m)
Debt / FCF = -1.42 (Net Debt -117.1m / FCF TTM 82.4m)
Total Stockholder Equity = 905.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 74.5m / Total Assets 1.72b)
RoE = 8.22% (Net Income TTM 74.5m / Total Stockholder Equity 905.7m)
RoCE = 10.30% (EBIT 106.2m / Capital Employed (Equity 905.7m + L.T.Debt 126.0m))
RoIC = 7.50% (NOPAT 78.2m / Invested Capital 1.04b)
WACC = 10.01% (E(948.7m)/V(956.5m) * Re(9.94%) + D(7.87m)/V(956.5m) * Rd(24.33%) * (1-Tc(0.26)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.96%
[DCF Debug] Terminal Value 61.75% ; FCFF base≈175.2m ; Y1≈115.0m ; Y5≈52.5m
Fair Price DCF = 40.15 (EV 763.9m - Net Debt -117.1m = Equity 881.0m / Shares 21.9m; r=10.01% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -44.81 | EPS CAGR: -49.71% | SUE: -4.0 | # QB: 0
Revenue Correlation: -74.69 | Revenue CAGR: -4.06% | SUE: -1.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.99 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=4
EPS current Year (2026-06-30): EPS=4.23 | Chg30d=+0.155 | Revisions Net=+4 | Growth EPS=+18.5% | Growth Revenue=+3.4%
EPS next Year (2027-06-30): EPS=4.73 | Chg30d=+0.011 | Revisions Net=+2 | Growth EPS=+11.8% | Growth Revenue=+4.5%